He also led and directed several NIH-sponsored projects at Thomas Jefferson University and did his postdoctoral fellowship at Indiana University-Purdue University at Indianapolis (IUPUI).
Director of Communications and Development Raeka Aiyar, Ph.
He worked most recently at Med Immune Inc., where he was a team leader on various projects involving pre-clinical/clinical biomarker assay development/validation and managed several cross functional teams across to qualify and validate clinical biomarker assays; CTC's, SNP's, vaccine immunogenicity, B and T-cell proliferation & repertoire analysis.
Elucidating the role of androgen receptor in breast cancer
His main interests include development and validation of human (both normal and cancer) biospecimen integrity markers using proteomic and molecular approaches and novel biomarkers for cancer treatment and diagnosis.
He directs and leads Biospecimen Research Network (BRN)-PI-led projects on human biospecimen integrity and biomarker development by studying preanalytical variables using proteomics and molecular approaches.
In her current role, she oversees and implements scientific communications at SGTC, including a heavy focus on fundraising, scientific strategy, program management, outreach, and collaboration building.
Her main areas of scientific focus – and those of SGTC – are precision health approaches, functional genomics, developing technologies for molecular and cellular characterization, and synthetic biology.
He was VP, Bioinformatics at Variagenics - one of the first companies to work on pharmacogenomics/human genetic variation, and led a key project at the National Cancer Institute to integrate oncology care and research data. Adams is visiting faculty at the Center for Science and Industry at Bentley University, and has also held senior positions with Booz Allen Hamilton, Bridgewater Associates, and Good Start Genetics. Addario Lung Cancer Foundation (ALCF) in 2006, and then went on to found the Addario Lung Cancer Medical Institute (ALCMI) with her husband, Tony Addario, in 2008.
Bonnie’s business acumen and skills honed in her first career as President of Olympian Oil Company and Commercial Fueling Network (CFN), as Past President of the CA Independent Oil Marketers Association (CIOMA) and as a community activist serving on diverse boards have all contributed to her work at ALCF in developing business strategies and being the Foundation’s patient voice at national/international conferences, on panels and boards, and to industry leaders, clinicians and policy makers.In collaboration with the Derynck lab, we also investigate detailed molecular mechanisms regulating TGFβ-driven EMT in cancer.We also have a strong interest in cellular and molecular mechanisms driving abnormal angiogenesis in the human genetic disorder HHT, which is caused by functional loss of a single allele of one of the genes encoding TGFβ/BMP signaling molecules, endoglin, ACVRL1/Alk1, or Smad4.Most recently, she was recognized for her work in the field of digital image analysis with the 2017 Distinguished Early Career Award from the Society of Toxicologic Pathology. He has published extensively on antioxidant gene therapy approaches against neuroinflammation/neurodegeneration, dopaminergic neurons apoptosis, rat models of ischemia, role of caspases, metalloproteinases and VEGF.Program Director, Biorepositories and Biospecimen Research Branch (BBRB), Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis Lokesh Agrawal earned his Ph. from All India Institute of Medical Sciences, India and did his M. He was the first one to show the Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type I in primary CD4 cells using recombinant Adenoviruses and has developed assays to quantify viruses in blood.Worked and lived in NL as well as USA prior to joining Digital Pathology Solutions in 2011.